A detailed history of Captrust Financial Advisors transactions in Danaher Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 102,899 shares of DHR stock, worth $24 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
102,899
Previous 106,263 3.17%
Holding current value
$24 Million
Previous $26.5 Million 7.74%
% of portfolio
0.09%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$239.25 - $280.76 $804,837 - $944,476
-3,364 Reduced 3.17%
102,899 $28.6 Million
Q2 2024

Aug 14, 2024

BUY
$235.51 - $267.98 $601,257 - $684,152
2,553 Added 2.46%
106,263 $26.5 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $4.29 Million - $4.9 Million
-19,121 Reduced 15.57%
103,710 $25.9 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $42,573 - $53,619
-230 Reduced 0.19%
122,831 $28.4 Million
Q3 2023

Nov 14, 2023

BUY
$233.08 - $265.59 $1.38 Million - $1.57 Million
5,907 Added 5.04%
123,061 $30.5 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $364,933 - $415,459
-1,622 Reduced 1.37%
117,154 $28.1 Million
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $1.28 Million - $1.47 Million
5,324 Added 4.69%
118,776 $29.9 Million
Q4 2022

Feb 15, 2023

SELL
$241.42 - $282.29 $907,256 - $1.06 Million
-3,758 Reduced 3.21%
113,452 $30.1 Million
Q3 2022

Nov 16, 2022

BUY
$247.06 - $1507.4 $3.01 Million - $18.4 Million
12,183 Added 11.6%
117,210 $30.3 Million
Q2 2022

Aug 23, 2022

SELL
$237.11 - $299.66 $2.24 Million - $2.83 Million
-9,455 Reduced 8.26%
105,027 $26.7 Million
Q2 2022

Aug 16, 2022

BUY
$237.11 - $299.66 $2.08 Million - $2.62 Million
8,756 Added 8.28%
114,482 $29 Million
Q1 2022

May 16, 2022

BUY
$257.27 - $315.76 $6.02 Million - $7.39 Million
23,418 Added 28.45%
105,726 $31 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $255,862 - $288,212
-876 Reduced 1.05%
82,308 $27.1 Million
Q3 2021

Nov 16, 2021

SELL
$272.21 - $332.43 $843,306 - $1.03 Million
-3,098 Reduced 3.59%
83,184 $25.3 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $187,491 - $226,317
-833 Reduced 0.96%
86,282 $23.2 Million
Q1 2021

May 17, 2021

BUY
$212.38 - $245.9 $280,766 - $325,079
1,322 Added 1.54%
87,115 $19.6 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $328,100 - $378,990
1,544 Added 1.83%
85,793 $19.1 Million
Q3 2020

Nov 17, 2020

SELL
$177.16 - $215.33 $1.55 Million - $1.88 Million
-8,737 Reduced 9.4%
84,249 $18.1 Million
Q2 2020

Aug 14, 2020

BUY
$128.7 - $176.83 $986,871 - $1.36 Million
7,668 Added 8.99%
92,986 $16.5 Million
Q1 2020

May 15, 2020

SELL
$121.39 - $169.05 $632,320 - $880,581
-5,209 Reduced 5.75%
85,318 $11 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $3.6 Million - $4.14 Million
27,001 Added 42.5%
90,527 $14.1 Million
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $251,844 - $272,434
-1,860 Reduced 2.84%
63,526 $9.18 Million
Q2 2019

Aug 13, 2019

SELL
$124.88 - $143.73 $143,487 - $165,145
-1,149 Reduced 1.73%
65,386 $9.36 Million
Q1 2019

May 15, 2019

SELL
$97.62 - $132.29 $266,112 - $360,622
-2,726 Reduced 3.94%
66,535 $8.8 Million
Q4 2018

Feb 13, 2019

SELL
$94.85 - $109.54 $195,106 - $225,323
-2,057 Reduced 2.88%
69,261 $7.15 Million
Q3 2018

Nov 15, 2018

BUY
$98.13 - $108.9 $571,999 - $634,778
5,829 Added 8.9%
71,318 $7.76 Million
Q2 2018

Aug 13, 2018

SELL
$96.1 - $103.24 $73,804 - $79,288
-768 Reduced 1.16%
65,489 $6.47 Million
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $369,745 - $416,445
-4,012 Reduced 5.71%
66,257 $6.38 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $123,030 - $136,536
1,443 Added 2.1%
70,269 $6.53 Million
Q3 2017

Feb 16, 2018

BUY
$79.29 - $88.45 $5.46 Million - $6.09 Million
68,826
68,826 $6.54 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.